Search the AAJ Exchange for materials from this education program »
Presented with AAJ's SSRI Antidepressant Birth Defect Cases Litigation Group
Selective Serotonin Reuptake Inhibitors (SSRIs), such as Prozac, Zoloft, Paxil, Celexa, and Lexapro, are commonly prescribed drugs used to treat depression, anxiety, and personality disorders. AAJ’s Selective Selective Serotonin Reuptake Inhibitor (SSRIs) Case Evaluation and Screening Teleseminar will provide an in-depth look at the link between the use of SSRIs during pregnancy and potential birth and developmental defects, such as pulmonary hypertension, hypoplastic left heart, and conotruncal defects. Issuing its first Public Health Advisory warning in December of 2005, the FDA has issued additional warnings of the dangers of SSRIs taken during pregnancy. Through exploration of SSRI history, as well as recent studies, the faculty will delve into information and strategies that will help plaintiff lawyers understand how to proceed with current litigation, including an update on the Zoloft MDL.
Moderator Instructions
Harris L. Pogust, PA
The Science and Background of Selective Serotonin Reuptake Inhibitors (SSRIs) and Zoloft MDL Litigation Update
Sean Patrick Tracey, TX
Case Evaluation and Screening
• Filing Dates
Jennifer R. Liakos, CA
Question and Answer Session
Contribute to the AAJ Education Fund
Please consider a donation to the AAJ Education Fund 501(c)(3). Contributions support educational programs and activities to preserve and protect the civil justice system.
Learn more »
